Search | IOVS | ARVO Journals

Showing 1 – 20 of 39

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

SPVN06, a novel mutation-independent AAV-based gene therapy, dramatically reduces vision loss in the rd10 mouse model of rod-cone dystrophy

Florence Lorget; Melanie Marie; Hanen Khabou; Cardillia Simon; Didier Nuno; Phillip Vanlandingham; Alain Quiambao; Rafal Farjo; Deniz Dalkara; Jose Alain Sahel; Thierry D Leveillard

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):56 – A0029. doi:

ARVO Annual Meeting Abstract July 2019

Topical application of Cyclosporine-A-MiDROPS™ for treatment of Autoimmune Uveitis

Terry G Coursey; Phillip A Vanlandingham; Ashley K. Sparkes; Drew Wassel; Alexander B Quiambao; Didier J Nuno; Rafal Farjo

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):790. doi:

Articles October 2018

Once-Daily Cyclosporine-A-MiDROPS for Treatment of Dry Eye Disease

PDF

Terry G. Coursey; Ronald A. Wassel; Alexander B. Quiambao; Rafal A. Farjo
TAGS: cyclosporine, dry eye syndromes
Trans. Vis. Sci. Tech.. 2018; 7(5):24. doi: https://doi.org/10.1167/tvst.7.5.24

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2018

Once-a-day Cyclosporine-A-MiDROPS™ for treatment of dry eye disease

Terry G. Coursey; Drew Wassel; Alexander Quiambao; Aaron J Dockins; David G Dillion; James R Johnson; Lynsie M Morris; Mandy L Lambros; Rafal Farjo

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4951. doi:

Retina September 2017

Transgenic Mice Over-Expressing RBP4 Have RBP4-Dependent and Light-Independent Retinal Degeneration

PDF

Mei Du; Eric Phelps; Michael J. Balangue; Aaron Dockins; Gennadiy Moiseyev; Younghwa Shin; Shelley Kane; Laura Otalora; Jian-Xing Ma; Rafal Farjo; Krysten M. Farjo
TAGS: mice, retinal degeneration, mice, transgenic, electroretinography, retinoids
Invest. Ophthalmol. Vis. Sci.. 2017; 58(10):4375-4383. doi: https://doi.org/10.1167/iovs.17-22107

ARVO Annual Meeting Abstract June 2017

Laser-induced Choroidal Neovascularization in the Yucatan Minipig – Characterization of a Novel Model of Neovascular Age-Related Macular Degeneration

Ryan F. Boyd; Douglas B. Snider; Krishna Yekkala; Betsy M. Geddings; Victoria J. Stevenson; Ashley Sparkes; Alexander Quiambao; Didier J. Nuno; Rafal Farjo; Thomas S Vihtelic; Joshua T Bartoe

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2303. doi:

Physiology and Pharmacology April 2017

Inhibition of Stat3 by a Small Molecule Inhibitor Slows Vision Loss in a Rat Model of Diabetic Retinopathy

PDF

Phillip A. Vanlandingham; Didier J. Nuno; Alexander B. Quiambao; Eric Phelps; Ronald A. Wassel; Jian-Xing Ma; Krysten M. Farjo; Rafal A. Farjo
TAGS: blindness, diabetes mellitus, diabetic retinopathy, rats, small molecule, stat3 protein, streptozocin, cataract, retina
Invest. Ophthalmol. Vis. Sci.. 2017; 58(4):2095-2105. doi: https://doi.org/10.1167/iovs.16-20641

ARVO Annual Meeting Abstract September 2016

Efficacy of Suprachoroidal Aflibercept in a Laser Induced Choroidal Neovascularization Model

Samirkumar Rajnikant Patel; Jennifer Kissner; Rafal Farjo; Vladimir Zarnitsyn; Glenn Noronha

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):286. doi:

ARVO Annual Meeting Abstract September 2016

Potency Assay for AAV Vector Encoding Retinal Pigment Epithelial 65 Protein

Linda B Couto; George Buchlis; Rafal Farjo; Katherine High

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):759. doi:

ARVO Annual Meeting Abstract September 2016

MiDROPS™ for Topical Delivery of Lipophilic Compounds to the Anterior and Posterior Segment of the Eye

Drew Wassel; Courtney Calbert; Didier Nuno; Alexander Quiambao; Jodi Green; Phillip Vanlandingham; A.J. Dockins; Ashley Sparkes; Eric Phelps; Mandy Lambros; Rafal Farjo

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi:

ARVO Annual Meeting Abstract June 2015

Transgenic Mice Over-Expressing Serum Retinol-Binding Protein have Progressive Inner Retinal Degeneration Caused by a Retinoid-Independent Mechanism

Krysten M Farjo; Laura Otalora; Mei Du; Ashley Martin; Gennadiy P Moiseyev; Phillip Vanlandingham; Rafal Farjo; Alexander Quiambao

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5425. doi:

ARVO Annual Meeting Abstract April 2014

PRI-724 Significantly Reduces Retinal Fibrosis in Models of CNV and PVR

Andy Whitlock; Rafal Farjo; Geoffrey P Lewis; Steven K Fisher; Gabriel Luna; Takenao Odagami; Tetsushi Inada; Hiroyuki Kouji

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1203. doi:

ARVO Annual Meeting Abstract April 2014

Oral delivery of CLT-005, a Stat3 inhibitor, prevents visual acuity decline in an animal model of type 1 diabetes

Rafal Farjo; Phillip Vanlandingham; Alexander Quiambao; Jodi Green; Didier J Nuno; Fadee Mondalek; Drew Wassel

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2248. doi:

ARVO Annual Meeting Abstract April 2014

Over-expression of RBP4 Causes Progressive Retinal Degeneration in Mice

Krysten M Farjo; Laura Otalora; TJ Hollingsworth; Rafal Farjo; Alexander Quiambao

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3478. doi:

ARVO Annual Meeting Abstract April 2014

Development of Fenofibrate Eyedrop Emulsions for Targeted Delivery Into the Eye

Drew Wassel; Rafal Farjo; Fadee Mondalek

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4617. doi:

ARVO Annual Meeting Abstract June 2013

Development of a Microemulsion Library for Drug Screening

Drew Wassel; Fadee Mondalek; Alexander Quiambao; Rafal Farjo

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1405. doi:

ARVO Annual Meeting Abstract June 2013

Eyedrop application of CLT-005, a Stat3 inhibitor, is efficacious in animal models of Wet and Dry Age-related Macular Degeneration

Rafal Farjo; Didier Nuno; Alexander Quiambao; Phillip Vanlandingham; Fadee Mondalek; Eric Phelps; Glenn Stoller; Drew Wassel

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1716. doi:

ARVO Annual Meeting Abstract March 2012

Development of Microemulsions for Enhanced Topical Delivery to the Eye

Ronald A. Wassel; Didier Nuno; Alexander Quiambao; Fadee Mondalek; Rafal Farjo

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):497. doi:

ARVO Annual Meeting Abstract April 2010

Topical Ophthalmic Emulsion for Treatment of Retinal Vasculopathy

R. A. Wassel; D. Chen; D. J. Nuno; A. B. Quiambao; J. L. Chodnicki; P. Margaron; J.-X. Ma; R. Farjo

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):2446. doi:

ARVO Annual Meeting Abstract April 2009

Pharmacokinetic Measurements of a Sustained Drug Delivery System

R. A. Wassel; D. Chen; D. J. Nuno; A. B. Quiambao; J. L. Chodnicki; Y. Hu; P. Margaron; J.-X. Ma; R. Farjo

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):5952. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

SPVN06, a novel mutation-independent AAV-based gene therapy, dramatically reduces vision loss in the rd10 mouse model of rod-cone dystrophy

Topical application of Cyclosporine-A-MiDROPS™ for treatment of Autoimmune Uveitis

Once-Daily Cyclosporine-A-MiDROPS for Treatment of Dry Eye Disease

Once-a-day Cyclosporine-A-MiDROPS™ for treatment of dry eye disease

Transgenic Mice Over-Expressing RBP4 Have RBP4-Dependent and Light-Independent Retinal Degeneration

Laser-induced Choroidal Neovascularization in the Yucatan Minipig – Characterization of a Novel Model of Neovascular Age-Related Macular Degeneration

Inhibition of Stat3 by a Small Molecule Inhibitor Slows Vision Loss in a Rat Model of Diabetic Retinopathy

Efficacy of Suprachoroidal Aflibercept in a Laser Induced Choroidal Neovascularization Model

Potency Assay for AAV Vector Encoding Retinal Pigment Epithelial 65 Protein

MiDROPS™ for Topical Delivery of Lipophilic Compounds to the Anterior and Posterior Segment of the Eye

Transgenic Mice Over-Expressing Serum Retinol-Binding Protein have Progressive Inner Retinal Degeneration Caused by a Retinoid-Independent Mechanism

PRI-724 Significantly Reduces Retinal Fibrosis in Models of CNV and PVR

Oral delivery of CLT-005, a Stat3 inhibitor, prevents visual acuity decline in an animal model of type 1 diabetes

Over-expression of RBP4 Causes Progressive Retinal Degeneration in Mice

Development of Fenofibrate Eyedrop Emulsions for Targeted Delivery Into the Eye

Development of a Microemulsion Library for Drug Screening

Eyedrop application of CLT-005, a Stat3 inhibitor, is efficacious in animal models of Wet and Dry Age-related Macular Degeneration

Development of Microemulsions for Enhanced Topical Delivery to the Eye

Topical Ophthalmic Emulsion for Treatment of Retinal Vasculopathy

Pharmacokinetic Measurements of a Sustained Drug Delivery System

To View More...

You must be signed into an individual account to use this feature.